Samoudi Ghazaleh, Jivegård Maria, Mulavara Ajitkumar P, Bergquist Filip
Department of Pharmacology, Inst of Neuroscience and Physiology, University of Gothenburg, Box 431, 405 30 Göteborg, Sweden.
Universities Space Research Association, Houston, TX, USA.
Brain Stimul. 2015 May-Jun;8(3):474-80. doi: 10.1016/j.brs.2014.11.019. Epub 2014 Dec 3.
Balance problems contribute to reduced quality of life in Parkinson's disease (PD) and available treatments are often insufficient for treating axial and postural motor symptoms.
To investigate the safety of use and possible effects of stochastic vestibular stimulation (SVS) alone and combined with LDOPA in patients with PD.
SVS or sham stimulation was administered to 10 PD patients in a double-blind placebo controlled cross-over pilot study. Motor symptoms and balance were evaluated in a defined off-medication state and after a 200 mg test dose of LDOPA, using UPDRS-III, Posturo-Locomotor-Manual (PLM) movement times (MT), static posturography and force plate measurements of the correcting response to a balance perturbation.
Patients did not detect when SVS was active, but SVS increased nausea after LDOPA in two patients. Mixed model analysis demonstrated that SVS improved balance corrections after a backward perturbation and shortened the postural response time. In static posturography there was significant interaction between effects of SVS, medication and proprioceptive input (standing on foam vs. on hard support) and SVS decreased the total sway-path with eyes closed and off medication. As expected, LDOPA improved the UPDRS-III scores and MT. There was an interaction between the effect of SVS and LDOPA on UPDRS-III partly because of reduced UPDRS-III scores with SVS in the off-medication state.
Short term use of SVS is safe, improves corrective postural responses and may have a small positive effect on motor symptoms in PD patients off treatment.
平衡问题会导致帕金森病(PD)患者生活质量下降,现有的治疗方法往往不足以治疗轴向和姿势性运动症状。
研究随机前庭刺激(SVS)单独使用以及与左旋多巴联合使用对PD患者的安全性及可能产生的影响。
在一项双盲安慰剂对照交叉试验性研究中,对10例PD患者给予SVS或假刺激。在明确的未用药状态下以及给予200mg左旋多巴试验剂量后,使用统一帕金森病评定量表第三部分(UPDRS-III)、姿势-运动-手动(PLM)运动时间(MT)、静态姿势描记法以及力平台测量对平衡扰动的纠正反应,评估运动症状和平衡情况。
患者无法察觉SVS何时激活,但有两名患者在服用左旋多巴后SVS增加了恶心感。混合模型分析表明,SVS改善了向后扰动后的平衡纠正,并缩短了姿势反应时间。在静态姿势描记法中,SVS、药物治疗和本体感觉输入(站在泡沫上与硬支撑上)的效果之间存在显著交互作用,且SVS在闭眼且未用药状态下减少了总摆动路径。正如预期的那样,左旋多巴改善了UPDRS-III评分和MT。SVS和左旋多巴对UPDRS-III的影响之间存在交互作用,部分原因是在未用药状态下SVS使UPDRS-III评分降低。
短期使用SVS是安全的,可改善姿势纠正反应,并且可能对未接受治疗的PD患者的运动症状有轻微的积极影响。